Open Access
Subscription or Fee Access
Insight into the Manifestation of Hyperlipidemia and its Amelioration by Natural Resources
Abstract
Hyperlipidemia is among the most important dangerous elements for the. Cardiovascular disease high rate the leading causes of mortality include coronary heart disease, stroke, atherosclerosis, and hyperlipidemia. blood total and (LDL) cholesterol increase have been identified as crucial contributors to CVD risk. Hyperlipidemia is a disorder in which the blood has unusually high quantities of lipid or fatty compounds. To avoid atherosclerosis-related illnesses, hypolipidemic medications are commonly utilized as preventive medicines. These hypolipidemic medications, however, are not without side effects. Many plant extracts and home treatments have been studied for their ability to lower cholesterol levels. Medicinal herbs play a big impact on lowering cholesterol levels.
References
Hashemzadeh K, Dehdilani M. International Journal of New Chemistry Evaluation of Hyperlipidemia in Patients Candidates for Coronary Artery Bypass Graft Surgery Hyperlipidemia is a known risk factor for coronary artery disease and the progression of. 2022;0–1.
Kuzmich, Nikolay, et al. "PCSK9 As A Target For Development Of A New Generation Of Hypolipidemic Drugs". Molecules, vol 27, no. 2, 2022, p. 434. MDPI AG, https://doi.org/10.3390/molecules27020434. Accessed 29 June 2022.
Rukmini C, Raghuram TC. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. Journal of the American College of Nutrition. 1991 Dec 1;10(6):593-601.
Zhang, Q., Wang, H., Feng, Z., Lu, Z., Su, C., Zhao, Y., ... & Su, W. (2021). Preparation of pectin-tannic acid-coated core-shell nanoparticle for enhanced bioavailability and antihyperlipidemic activity of curcumin. Food Hydrocolloids, 119, 106858.
Irshad, N., Khan, A. U., Shah, F. A., Nadeem, H., Ashraf, Z., Tipu, M. K., & Li, S. (2021). Antihyperlipidemic effect of selected pyrimidine derivatives mediated through multiple pathways. Fundamental & Clinical Pharmacology, 35(6), 1119-1132.
Tzara, A., Lambrinidis, G., & Kourounakis, A. (2021). Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity. Molecules, 26(16), 4928.
Shehata, T. M., Khalil, H. E., Elsewedy, H. S., & Soliman, W. E. (2021). Myrrh essential oil-based nano lipid formulation for enhancement of the antihyperlipidemic effect of atorvastatin. Journal of Drug Delivery Science and Technology, 61, 102277.
Ojuade, F. I., Olorundare, O. E., Akanbi, O. B., Afolabi, S. O., & Njan, A. A. (2021). Antidiabetic and antihyperlipidemic effects of aqueous extract of Parquetina nigrescens in streptozotocin–nicotinamide induced type 2 diabetic rats. Heliyon, 7(6), e07363.
Lipman TH, Hayman LL, Fabian CV, DiFazio DA, Hale PM, Goldsmith BM, et al. Risk factors for cardiovascular disease in children with type I diabetes. Nurs Res 2000; 49:160-166
Bonaterra-Pastra, Anna et al. "Comparison Of Plasma Lipoprotein Composition And Function In Cerebral Amyloid Angiopathy And Alzheimer’S Disease". Biomedicines, vol 9, no. 1, 2021, p. 72. MDPI AG, https://doi.org/10.3390/biomedicines9010072. Accessed 29 June 2022.
Littmann, Karin et al. "Plasma Lipoprotein(A) Measured In The Routine Clinical Care Is Associated To Atherosclerotic Cardiovascular Disease During A 14-Year Follow-Up". European Journal Of Preventive Cardiology, vol 28, no. 18, 2021, pp. 2038-2047. Oxford University Press (OUP), https://doi.org/10.1093/eurjpc/zwab016. Accessed 13 June 2022.
Jonas, A. Lipoprotein structure In: (Vance DE, Vance JE), Biochemistry of Lipids, Lipoproteins and Membranes, 4thedn, Amsterdam: Elsevier, 2002; pp483–504.
Harvey, R. A., Ferrier, D. R. Cholesterol and steroid metabolism In: (Rhyner, S.), Biochemistry, 5th edn, USA: Lippincott Williams & Wilkins, 2011; pp227-237
McLaren J. E., Michael D. R., Ashlin T. G., Ramji D. P.Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy.Prog. Lipid Res., 50(4):331–347 (2011).
Ezeh, Kosisochukwu J, and Obiora Ezeudemba. "Hyperlipidemia: A Review Of The Novel Methods For The Management Of Lipids". Cureus, 2021. Cureus, Inc., https://doi.org/10.7759/cureus.16412. Accessed 13 June 2022
Joseph, D. Pharmacotherapy, A pathophysiological approach, 8thedn, The McGraw Hill companies, Inc. 2011; pp370
Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med. 1971 Sep;75(3):471-2.
Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J., American Heart Association. Atherosclerotic Vascular Disease
Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. Circulation. 2017 Nov 14;136(20):1878-1891.
Ford I, Murray H, McCowan C, Packard CJ. Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study. Circulation. 2016 Mar 15;133(11):1073-80
Björkegren, Johan L.M., and Aldons J. Lusis. "Atherosclerosis: Recent Developments". Cell, vol 185, no. 10, 2022, pp. 1630-1645. Elsevier BV, https://doi.org/10.1016/j.cell.2022.04.004. Accessed 29 June 2022.
Kuzmich, Nikolay et al. "PCSK9 As a Target for Development of A New Generation Of Hypolipidemic Drugs". Molecules, vol27, no. 2, 2022, p. 434. MDPI AG, https://doi.org/10.3390/molecules27020434. Accessed 13 June 2022
Zhang, Qing et al. "Signaling Pathways And Targeted Therapy For Myocardial Infarction". Signal Transduction And Targeted Therapy, vol 7, no. 1, 2022. Springer Science And Business Media LLC, https://doi.org/10.1038/s41392-022-00925-z. Accessed 29 June 2022.
Chidambaram, Saravana Babu et al. "The Influence Of Gut Dysbiosis In The Pathogenesis And Management Of Ischemic Stroke". Cells, vol 11, no. 7, 2022, p. 1239. MDPI AG, https://doi.org/10.3390/cells11071239. Accessed 29 June 2022.Nickolas,
T.L.,Radhakrishnan, J.,Appel, G.B. Hyperlipidemia and thrombotic complications in patients with membranous nephropathy.Semin.Nephrol.; 23(4):406-11 (2003)
Amarenco, P., Labreuche, J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol., 8 (5): 453 – 463 (2009)
Xie, Liguo et al. "An Overview On The Biological Activity And Anti-Cancer Mechanism Of Lovastatin". Cellular Signalling, vol 87, 2021, p. 110122. Elsevier BV, https://doi.org/10.1016/j.cellsig.2021.110122. Accessed 24 June 2022.
K.V. Sashidhara, M. Kumar, R. Sonkar, B.S. Singh, A.K. Khanna, G. Bhatia, Indole-based fibrates as potential hypolipidemic and antiobesity agents, J. Med. Chem. 55 (2012) 2769e2779.
S. Dev, Ancient-modern concordance in Ayurvedic plants: some examples, Environ. Health Perspect. 107 (1999) 783e789.
P.S. Phillips, R.H. Haas, S. Bannykh, S. Hathaway, N.L. Gray, B.J. Kimura, G.D. Vladutiu, J.D. England, Statin-associated myopathy with normal creatine kinase levels, Ann. Intern. Med. 137 (2002) 581e585.
Murugesa Mudhaliar. Gunapadam Mooligai Vaguppu. Dept of Indian Medicine and Homeopathy, Chennai. Govt. of Tamilnadu.2006 (1)70-480.
Champe PC, Harvey RA, Ferrier DR. Cholesterol and Steroid Metabolism. In: Lippincott’s Illustrated Review- Biochemistry. 3rd edition. Lippincott Williams and Wilkins, Philadelphia.2005(1) 217- 242
Srikanth Jeyabalan, Muralidharan Palayan. Antihyperlipidemic activity of Sapindus emarginatus in Triton WR-1339 induced albino rats. Research Journal. Pharm. and Technology .2009 (2))
Murugesa Mudhaliar. Gunapadam Mooligai Vaguppu. Dept of Indian Medicine and Homeopathy, Chennai. Govt. of Tamilnadu.2006 (1)70-480.
Varsha Dhulasavant, Shubhangi Shinde, Mangesh Pawar Anti0hyperlipidemic Activity of Cinnamomum tamala Nees. On High Cholesterol Diet Induced Hyperlipidemia. International Journal of PharmTech Research.2010, 2(4): 2517- 2521
Kanakavalli K, Thillaivanan S, Parthiban P, Vijayalakshmi G, Sudha M, Sutha J Antihyperlipidemic herbs in siddha system of medicine,2014. (3) 541-545.
Oben J, Kuate D, Agbor G The use of Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids in Health and Disease.2006 (5) 24
A. Hernandez, M.L. Lopez, G. Chamorro, T. Mendoza-Figueroa, Inhibition of lipid synthesis and secretion in long-term cultures of adult rat hepatocytes by alpha-asarone, Planta Med. 59 (1993) 121e124.
L. Garduno, M. Salazar, S. Salazar, M.E. Morelos, F. Labarrios, J. Tamariz, G.A. Chamorro, Hypolipidaemic activity of alpha-asarone in mice, J. Ethnopharmacol. 55 (1997) 161e163.
G. Chamorro, M. Salazar, S. Salazar, T. Mendoza, Pharmacology and toxicology of Guatteria gaumeri and alpha-asarone, Rev. Invest. Clin. 45 (1993) 597e604.
C. Gomez, G. Chamorro, M.A. Chavez, G. Martinez, M. Salazar, N. Pages, Effet de alpha-asarone sur l¢hypercholesterolemie et la cholelithiasis experimentales, Plant. Med. Phytother. 21 (1987) 279e284.
L. Rodriguez-Paez, M. Juarez-Sanchez, J. Antunez-Solis, I. Baeza, C. Wong, Alpha-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats, Phytomedicine 10 (2003) 397e404.
V. Sudhahar, A.S. Kumar, P. Varalakshmi, Role of lupeol and lupeol linoleate on lipemicoxidative stress in experimental hypercholesterolemia, Life Sci. 78 (2006) 1329-1335.
K. Sato, S. Mizuno, M. Hirayama, A total synthesis of phytol, J. Org. Chem. 32(1967) 177-180.
A. Schluter, P. Yubero, R. Iglesias, M. Giralt, F. Villarroya, b-The chlorophyllderived metabolite phytanic acid induces white adipocyte differentiation, Int. J. Obes. Relat. Metab. Disord. 26 (2002)1277-1280.
A. Schluter, M. Giralt, R. Iglesias, F. Villarroya, c-Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation, FEBS Lett. 517 (2002) 83-86.
A. Schluter, M.J. Barbera, R. Iglesias, M. Giralt, F. Villarroya, a-Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation, Biochem. J. 362 (2002) 61-69.
T. Narender, S. Shweta, P. Tiwari, K. Papi Reddy, T. Khaliq, et al, Antihyperglycemic and antidyslipidemic agent from Aegle marmelos, Bioorg. Med. Chem. Lett. 17 (2007) 1808-1811.
C. Williams, O.A. Espinosa, H. Montenegro, L. Cubilla, T.L. Capson, E. Ortega-Barria, L.I. Romero, Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania, J. Microbiol. Methods 55 (2003) 813-816.
A. Patra, A.K. Mitra, A. Ghosh, P.K. Mukhopadhyay, Carbon-13 NMR spectra of tembamide, aegeline and related amides, Org. Magn. Res. 16 (1981) 65-67.
Refbacks
- There are currently no refbacks.